Cargando…

Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation

Aims: Multimodal imaging has allowed cardiac amyloidosis (CA) to be increasingly recognised as a treatable cause of heart failure with preserved ejection fraction, but its prognosis remains poor due to late diagnosis. To assess the left ventricular diastolic function (LVDF) patterns in a large conte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oghina, Silvia, Bougouin, Wulfran, Kharoubi, Mounira, Bonnefous, Louis, Galat, Arnault, Guendouz, Soulef, Bezard, Mélanie, Le Bras, Fabien, Deux, Jean-François, Itti, Emmanuel, Moktefi, Anissa, Fanen, Pascale, Teiger, Emmanuel, Mohty, Dania, Damy, Thibaud, Bodez, Diane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584963/ https://www.ncbi.nlm.nih.gov/pubmed/34768408 http://dx.doi.org/10.3390/jcm10214888

Ejemplares similares

History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
por: Kharoubi, Mounira, et al.
Publicado: (2021)

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment
por: Oghina, Silvia, et al.
Publicado: (2021)

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2020)

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
por: Bézard, Mélanie, et al.
Publicado: (2021)

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2023)

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
por: Guendouz, Soulef, et al.
Publicado: (2022)

Prevalence and determinants of iron deficiency in cardiac amyloidosis
por: Jobbé‐Duval, Antoine, et al.
Publicado: (2022)

Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study
por: Bodez, Diane, et al.
Publicado: (2016)

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
por: Broussier, Amaury, et al.
Publicado: (2021)

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
por: Abroud, Hajer, et al.
Publicado: (2022)

Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement
por: Galat, Arnault, et al.
Publicado: (2019)

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis
por: Galat, Arnault, et al.
Publicado: (2015)

Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism
por: Damy, Thibaud, et al.
Publicado: (2011)

Left ventricular and atrial function in systemic light chains amyloidosis: an echocardiography and cardiac magnetic resonance comparison
por: Mohty, Dania, et al.
Publicado: (2015)

Comparison and identification of early clinical, biological and echocardiographic prognostic markers in cardiac amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

Posterior longitudinal strain by speckle tracking echocardiography, marker of cardiac amyloidosis?
por: Ternacle, Julien, et al.
Publicado: (2015)

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
por: Ridouani, Fourat, et al.
Publicado: (2018)

Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants
por: Touboul, Olivier, et al.
Publicado: (2022)

Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
por: Gonzalez-Lopez, Esther, et al.
Publicado: (2022)

Transthyretin cardiac amyloidosis in Saudi Arabia and the Middle East: insights, projected prevalence and practical applications
por: Mohty, Dania, et al.
Publicado: (2023)

Severe Heart Failure Associated With Tachycardia-Induced Cardiomyopathy Due to Incessant Atrioventricular Re-Entrant Tachycardia
por: Moulin, Thibaut, et al.
Publicado: (2021)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Common physiological responses during TTM
por: Geri, Guillaume, et al.
Publicado: (2015)

Post-resuscitation shock: recent advances in pathophysiology and treatment
por: Jozwiak, Mathieu, et al.
Publicado: (2020)

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis
por: Law, Steven, et al.
Publicado: (2022)

Infections and Collapsing Glomerulopathy
por: Moktefi, Anissa, et al.
Publicado: (2020)

Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real‐world experience
por: Moulin, Thibaut, et al.
Publicado: (2022)

Positron Emission Tomography With (18)F-Fluorodeoxyglucose in Patients With Sickle Cell Acute Chest Syndrome
por: de Prost, Nicolas, et al.
Publicado: (2015)

Long-term heart function in cardiac-arrest survivors
por: Raphalen, Jean-Herlé, et al.
Publicado: (2023)

Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits
por: Morel, Antoine, et al.
Publicado: (2021)

Quantitative CT analysis for assessing response in lymphoma (Cheson’s criteria): Wednesday 5 October 2005, 08:30–10:00
por: Rahmouni, Alain, et al.
Publicado: (2005)

MRI and PET in monitoring response in lymphoma: Wednesday 5 October 2005, 08:30–10:00
por: Rahmouni, Alain, et al.
Publicado: (2005)

¿El hombre o la naturaleza?
por: Bonnefous, Edouard
Publicado: (1973)

El mundo superpoblado
por: Bonnefous, Edouard
Publicado: (1973)

Diagnosis and Management of Heart Failure in Elderly Patients from Hospital Admission to Discharge: Position Paper
por: Damy, Thibaud, et al.
Publicado: (2021)

Myocardite et maladie à COVID-19 : où en est-on ?
por: Fard, D., et al.
Publicado: (2020)

Reply to the letter regarding the article ‘Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study’
por: Damy, Thibaud, et al.
Publicado: (2021)

Belatacept inhibit human B cell germinal center development in immunodeficient mice
por: Samson, Chloé, et al.
Publicado: (2023)

Factors associated with circulatory death after out-of-hospital cardiac arrest: a population-based cluster analysis
por: Binois, Yannick, et al.
Publicado: (2023)

Whole body MRI and PET/CT in haematological malignancies
por: Lin, Chieh, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ru5n6pl4oa2c83o7tsgh5p5pis